A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Clinical trial NCT00338286 · COMPLETED

Trial details

NCT number: NCT00338286
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Neoplasm Metastasis

Start date: 2006-03-02
Primary completion: 2014-07-07
Enrollment: 2098

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.